Cargando…
p33ING1b regulates acetylation of p53 in oral squamous cell carcinoma via SIR2
BACKGROUND: Oral squamous cell carcinoma (OSCC), a form of head and neck squamous cell carcinoma (HNSCC) has a poor 5-year survival rate. OSCC patients are often treated with cisplatin but resistance to chemotherapy is often observed. This makes it important identification of alternative therapeutic...
Autores principales: | Li, Xiao-han, Li, Dan, Liu, Chang, Zhang, Ming-ming, Guan, Xiao-jiao, Fu, Ya-ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436958/ https://www.ncbi.nlm.nih.gov/pubmed/32831651 http://dx.doi.org/10.1186/s12935-020-01489-0 |
Ejemplares similares
-
Expression of the novel tumour suppressor p33(ING1) is independent of p53
por: Cheung, K-J J, et al.
Publicado: (2000) -
The ING4 Binding with p53 and Induced p53 Acetylation were Attenuated by Human Papillomavirus 16 E6
por: Guo, Yi, et al.
Publicado: (2013) -
MicroRNA-196b-5p promotes malignant progression of colorectal cancer by targeting ING5
por: Xin, He, et al.
Publicado: (2020) -
Expression of P33(ING1b) Protein in Colorectal Cancer
por: Fallahnezhad, Somayeh, et al.
Publicado: (2016) -
MTHFR C677T genetic polymorphism in combination with serum vitamin B(2), B(12) and aberrant DNA methylation of P16 and P53 genes in esophageal squamous cell carcinoma and esophageal precancerous lesions: a case–control study
por: Pan, Da, et al.
Publicado: (2019)